Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2007Seminars in Thrombosis and Hemostasis

No clinical study data is present in the provided text, which consists only of journal editorial board information.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Is platelet GPVI surface expression elevated in patients with acute coronary syndrome compared to stable angina and healthy controls?

Population

Patients with stable angina, patients with acute coronary syndrome (ACS), and healthy controls

Comparison

Measurement of platelet GPVI surface expression… vs Patients with stable angina and healthy controls

Design

Cross-sectional

Key result

No clinical study data is present in the provided text, which consists only of journal editorial board information.

Authors

BBBoris BigalkeHLHarald F. LangerTGTobias Geisler

Discussion

Loading...

Member takes

Overview

No study data on GPVI in ACS; leaves open its role as early marker.

Structured PICO

Is platelet GPVI surface expression elevated in patients with acute coronary syndrome compared to stable angina and healthy controls?

P
Population
Patients with stable angina, patients with acute coronary syndrome (ACS), and healthy controls
I
Intervention
Measurement of platelet GPVI surface expression by flow cytometry
C
Comparator
Patients with stable angina and healthy controls
O
Outcome
Platelet GPVI surface expressionsurrogate

Platelet GPVI expression is significantly elevated in ACS patients and rises earlier than traditional markers of myocardial necrosis, potentially serving as a novel early marker for acute coronary syndrome.

Cite This Study

Bigalke et al. (2007) studied this question. No clinical study data is present in the provided text, which consists only of journal editorial board information.

synapsesocial.com/papers/6a141b69a4182367b1628fc2https://doi.org/10.1055/s-2007-969032
View Full Paper
Ask AI
Bookmark
Share